KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $792000.0.

  • Biolife Solutions' Non Operating Income rose 69548.87% to $792000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 16110.7%. This contributed to the annual value of -$4.3 million for FY2024, which is 18645.6% down from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Non Operating Income is $792000.0, which was up 69548.87% from $931000.0 recorded in Q2 2025.
  • Biolife Solutions' Non Operating Income's 5-year high stood at $6.2 million during Q3 2021, with a 5-year trough of -$4.3 million in Q2 2024.
  • For the 5-year period, Biolife Solutions' Non Operating Income averaged around $608052.6, with its median value being $235000.0 (2023).
  • In the last 5 years, Biolife Solutions' Non Operating Income surged by 956666.67% in 2023 and then crashed by 18319.64% in 2024.
  • Quarter analysis of 5 years shows Biolife Solutions' Non Operating Income stood at $142000.0 in 2021, then soared by 152.11% to $358000.0 in 2022, then crashed by 81.01% to $68000.0 in 2023, then plummeted by 133.82% to -$23000.0 in 2024, then skyrocketed by 3543.48% to $792000.0 in 2025.
  • Its last three reported values are $792000.0 in Q3 2025, $931000.0 for Q2 2025, and $784000.0 during Q1 2025.